Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
申请人:Jirgensons Aigars
公开号:US20050197361A1
公开(公告)日:2005-09-08
The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutially acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
申请人:Jirgensons Aigars
公开号:US20050288284A1
公开(公告)日:2005-12-29
The invention relates to ethynyl-substituted tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
申请人:Kauss Valerjans
公开号:US20090227582A1
公开(公告)日:2009-09-10
The invention relates to ethynyl-substituted tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.